Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
Thought Leadership
Feb 04, 2025

‘First published on Lexology’ The India Cyber Threat Report 2025 by the Data Security Council of India identified Deepfake exploitation as one

Real or Fake? Dealing with Deepfakes Dilemma in Digital Society
Thought Leadership
Sep 25, 2024

‘First published on IAM‘ By: Vaishali R Mittal and Siddhant Chamola In summary This article covers the biggest judicial decisions in Indian patent

India: recent SEP rulings and evolving jurisprudence shaping patent landscape
News & Updates
Sep 19, 2024

Two key representatives from the World Intellectual Property Organization (WIPO) Madrid Registry visited our office on September 19 to understand the needs

WIPO representatives visit Anand and Anand office
News & Updates
Sep 13, 2024

Anand and Anand has been recognised as an ‘Outstanding Firm’ for Intellectual Property in the asialaw 2024 Rankings. We have also been ranked ‘Highly

Asialaw 2024 Rankings